Evidence map›Paper›PMID 39484212›Full record

ArticlePeerJ2024

An interpretable deep learning model for detecting

Yi Li, Xiaomin Xiong, Xiaohua Liu, Yihan Wu, Xiaoju Li, Bo Liu, Bo Lin, Yu Li, Bo Xu

Abstract read
In one paragraph

Article in PeerJ, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yi Li *School of Medicine, Chongqing University, Chongqing, China.
Xiaomin Xiong *School of Medicine, Chongqing University, Chongqing, China.ORCID 0009-0002-9916-5560
Xiaohua LiuBioengineering College of Chongqing University, Chongqing, China.
Yihan WuChongqing Key Laboratory for Intelligent Oncology in Breast Cancer, Chongqing University Cancer Hospital, Chongqing, China.
Xiaoju LiDepartment of Pathology, Chongqing University Cancer Hospital, School of Medicine, Chongqing University, Chongqing, China.
Bo LiuChongqing Key Laboratory for Intelligent Oncology in Breast Cancer, Chongqing University Cancer Hospital, Chongqing, China.
Bo LinChongqing Key Laboratory for Intelligent Oncology in Breast Cancer, Chongqing University Cancer Hospital, Chongqing, China.
Yu LiDepartment of Pathology, Chongqing University Cancer Hospital, School of Medicine, Chongqing University, Chongqing, China.
Bo XuSchool of Medicine, Chongqing University, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Determining the status of breast cancer susceptibility genes ( Methods: A total of 319 histopathological slides from 254 breast cancer patients were included, comprising two dependent cohorts. Following image pre-processing, 633,484 tumor tiles from the training dataset were employed to train the self-developed deep-learning model. The performance of the network was evaluated in the internal and external test sets. Results: BiAMIL achieved AUC values of 0.819 (95% CI [0.673-0.965]) in the internal test set, and 0.817 (95% CI [0.712-0.923]) in the external test set. To explore the relationship between Conclusions: An interpretable deep neural network model based on the attention mechanism was developed to predict the

Indexed as

Breast NeoplasmsDeep LearningEosine Yellowish-(YS)HematoxylinAdultAlgorithmsFemaleGenetic Predisposition to DiseaseHumansMiddle AgedMutationEosine Yellowish-(YS)HematoxylinBRCABreast cancerDeep learningInterpretabilitySelf-attention

Identifiers

PMID39484212
PMCPMC11526788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.